Literature DB >> 15174116

Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines.

Yan Yu1, Richard I Harris, Jia-Lin Yang, H Clarke Anderson, William R Walsh.   

Abstract

Differential expression of multiple osteogenic factors may be responsible for the different osteoinductivity of osteosarcoma cell lines. We compared in vivo osteoinductivity of human osteosarcoma cell lines (Saos-2 vs. U-2 OS) in nude mice, and their in vitro expression of various osteogenic factors of protein level by quantitative immunocytochemistry and mRNA level by RT-PCR and/or in situ hybridization. Saos-2 cells, but not U-2 OS, were osteoinductive in vivo. Significantly higher expression (independent t-test, all p < 0.005) of osteogenic factors were observed in Saos-2 cells compared with U-2 OS, which included bone morphogenetic proteins (particularly BMPs-2, 3, 4, and 7), transforming growth factor-beta (TGF-beta), BMP receptor (BMPR)-1A, receptor-regulated Smads (R-Smads), Smads 1, 2, and 5, and common-mediator Smad (Co-Smad), Smad 4. In contrast, U-2 OS cells expressed higher levels of inhibitory Smad 6 (I-Smad) protein than Saos-2 cells (p < 0.001). These results suggest that a combination of osteogenic factors (BMPs, TGF-beta, BMPRs, and R/Co-Smads) against I-Smad may play important roles in the Saos-2 cell osteoinductivity. This may have a clinical implication in selecting key osteogenic factors for combined therapy for bone defect diseases. The characterized cell lines can be used as positive and negative controls for the assessments of both in vitro and in vivo bone formation capabilities of designed tissues or biomaterials. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174116     DOI: 10.1002/jbm.a.30072

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  8 in total

Review 1.  Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing.

Authors:  Crispin R Dass; Eugene T H Ek; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-10       Impact factor: 4.553

Review 2.  Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?

Authors:  M Reza Sadaie
Journal:  Ther Adv Drug Saf       Date:  2011-12

3.  Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.

Authors:  Lin Du; Qiming Fan; Bing Tu; Wei Yan; Tingting Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 4.  Roles of bone morphogenetic protein signaling in osteosarcoma.

Authors:  Alan Nguyen; Michelle A Scott; Sarah M Dry; Aaron W James
Journal:  Int Orthop       Date:  2014-09-11       Impact factor: 3.075

Review 5.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

6.  alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression.

Authors:  Kaiyu Yuan; Leland W K Chung; Gene P Siegal; Majd Zayzafoon
Journal:  Lab Invest       Date:  2007-07-16       Impact factor: 5.662

7.  In Vitro Effects of PDGF Isoforms (AA, BB, AB and CC) on Migration and Proliferation of SaOS-2 Osteoblasts and on Migration of Human Osteoblasts.

Authors:  Alessandra Colciago; Fabio Celotti; Lavinia Casati; Rinaldo Giancola; Stefano M Castano; Guido Antonini; Maria Cristina Sacchi; Paola Negri-Cesi
Journal:  Int J Biomed Sci       Date:  2009-12

8.  Comparison of the reaction of bone-derived cells to enhanced MgCl2-salt concentrations.

Authors:  Anna Burmester; Bérengère Luthringer; Regine Willumeit; Frank Feyerabend
Journal:  Biomatter       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.